3781 results for «2023»
3781 results
RENOVATE-COMPLEX-PCI: Intravascular imaging-guided versus angiography-guided procedural optimization in complex percutaneous coronary intervention
06 Mar 2023
Daniele Giacoppo reports the main results of the RENOVATE-COMPLEX-PCI trial presented by Joo-Yong Hahn, from the Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, in a Late-Breaking Trial session at the American College of Cardiology (ACC) 2023 / World...
Author
What is the optimal aortic valve choice in the younger patient: transcatheter or surgery?
29 Nov 2023 – From PCR London Valves 2023
Follow the discussion between Darren Mylotte, Kentaro Hayashida and Ole De Backer to better understand the concept of "young patients" and what it exactly implies, and analyze how best to bring these specific patients to the end of their still potentially long life, by choosing the...
Patient selection for tricuspid intervention - the role of the right heart
30 Nov 2023 – From PCR London Valves 2023
Interviewed by Jörg Hausleiter, Rebecca Hahn and Philipp Lurz provide insight into the right heart's role in tricuspid procedures.
How can we best assess right heart function in patients so as to choose the most appropriate therapy for them? How TTE and TEE can help? How can...
DurAVR early safety and feasibility of a new class of biomimetic transcatheter aortic valve
05 Dec 2023 – From PCR London Valves 2023
DurAVR is a new TAVR valve which can mimic the shape of an original aortic valve. In this roundtable, Michael Reardon, Christopher Meduri, and Azeem Latib discuss this new technology, its key features, and the unmet medical needs it aims to answer. Find out more about...
TAVI pathway optimisation in Europe, insights and evidence
29 Nov 2023 – From PCR London Valves 2023
In this roundtable, Francesco Saia, Derk Frank and Douglas Muir discuss the need for TAVI pathway optimisation and Edwards' clinical project called Benchmark program, which comprises the best practices based on the evidence regarding pre- peri-and post-procedural TAVI phases.
This interview was filmed at PCR London Valves...
How can the latest long-term TAVI evidence impact our daily decision-making?
Join Antoinette Neylon, Didier Tchétché and Ole De Backer as they discuss the key issues in terms of lifetime management of TAVI patients, the learnings from the 10-year TAVI NOTION, the 4-year Evolut Low Risk, and the impact on initial device choice.
This interview was filmed at...
Treating a wide range of patient anatomies with the PASCAL implants
06 Dec 2023 – From PCR London Valves 2023
Sam Dawkins, Niklas Schofer and Mirjam Wild share the latest experience on Pascal implants for mitral and tricuspid TEER. Together they discuss the rationale for using the same device for mitral and tricuspid, how the skills and knowledge on MR can be used for TR,...
The revolution coming to tricuspid valve treatment with the EVOQUE replacement system
06 Dec 2023 – From PCR London Valves 2023
Marianna Adamo and Philipp Lurz summarize the results of the TRISCEND II randomized trial which addresses the question of transcatheter tricuspid replacement (using the EVOQUE system) vs OMT. Find out more about the key findings at 6 months and the relevance for your practice
This interview was...
Recent clinical evidence for mitral TEER the CLASP IID trial
06 Dec 2023 – From PCR London Valves 2023
What is the CLASP IID registry and what are the key learnings from 1-year data? Philipp Lurz and Jörg Hausleiter describe the methodology of the programme which compares Pascal vs Mitraclip in patients with degenerative mitral regurgitation. Discover the key findings which are relevant to your practice.
This...
What does lifetime management mean for the valve patient?
10 Jan 2024 – From PCR London Valves 2023
Bettina Kirk, Alexandra Baer and John Webb discuss the question of lifetime management for valve disease patients, and begin by outlining the main difficulties involved, offering both an interventional cardiologist's and a nurse's perspective.
Then, they are considering how this lifetime management could be improved in the...
Empowering European Healthcare Systems: RESIL-Card, an EU4Health Project, Launches to Enhance Cardiovascular Care Resilience
19 Jan 2024
Paris, 18 January 2024: The consortium and supporting partners that make up the RESIL-Card project kick-started the venture on 1st December 2023.
The 3-year project received a funding grant from the European Commission under the EU4Health Work Programme to strengthen European healthcare systems in providing continuity of care for...
How to prepare an excellent abstract for EuroPCR?
17 May 2023 – From EuroPCR 2023
Marjo De Ronde asks Davide Capodanno, Chief Editor of the EuroIntervention Journal, to describe the main steps for nurses, allied health professionals and researchers to get started with research.
If motivation and passion are the key words, the starting point remains the idea, which must be relevant, and...
Implications of TRILUMINATE, a randomized clinical trial of transcatheter repair for tricuspid regurgitation
17 May 2023 – From EuroPCR 2023
Listen to Nicole Karam and Fabien Praz talk about the latest update from the TRILUMINATE study, the very first randomized trial conducted to determine how to improve the prognosis of tricuspid regurgitation.
To do so, the study aimed at comparing optimal medical treatment with interventions with edge-to-edge repair.
The content...
Latest on TAVI in complex bicuspid lesions
17 May 2023 – From EuroPCR 2023
The bicuspid aortic valve is a real challenge in terms of diagnosis and treatment of patients, as discussed by Didier Tchétché and Raj Makkar in this interview.
Given that there are different phenotypes and patterns of calcification, some patients should indeed not be treated by TAVI: find out...
Should we perform revascularisation in patients with depressed left ventricle ejection fraction?
17 May 2023 – From EuroPCR 2023
Divaka Perera, main author of the REVIVED study, discusses the results of this trial with Flavio Ribichini.
REVIVE was a trial of severe ischaemic cardiomyopathy in which the primary outcome was death or heart failure hospitalization.The headline result was that there was absolutely no difference with PCI,...
What are the essential skillsets for aspiring transcatheter edge-to-edge mitral valve repair operators?
17 May 2023 – From EuroPCR 2023
Rebecca Hahn, interventional echocardiographer, and Sam Dawkins, interventional cardiologist, look at the skills a good fellow needs to become an excellent interventional cardiologist, particularly in relation to mitral interventions.
Mastery of imaging and the three-dimensional nature of the heart seems to be the key to success, but...
What is the best contemporary interventional management of out-of-hospital cardiac arrest?
17 May 2023 – From EuroPCR 2023
Thomas Keeble and Marko Noc tackle the tricky question of how to deal with a patient with out-of-hospital cardiac arrest.
While STEMI patients should almost invariably go directly to the cathlab, the situation seems less clear-cut for non-ST-elevation patients, for whom a genuinely personalized approach needs to be proposed.
Study...
When to use drug coated balloons in de novo lesions?
What areas are most subject to drug-coated balloon angioplasty in de novo lesions? Fernando Alfonso and Robert Byrne provide some answers in this interview, in which they list the scenarios in which this technology appears attractive.
Small vessel disease, diffuse disease, STEMI, side-branches and patients at high-bleeding risk are...
When should we perform PCI for stable coronary artery disease in aortic stenosis, pre, post, never?
17 May 2023 – From EuroPCR 2023
What is the evidence for the need for PCI in patients with stable coronary artery disease and severe aortic stenosis? Is invasive angiography always mandatory for these patients? What about CT scans? When exactly should PCI be performed?
These are the questions Vijay Kunadian and Martine Gilard...
What is the role of intra-coronary physiology and imaging to guide left main bifurcation PCI?
17 May 2023 – From EuroPCR 2023
As Alejandro Travieso explains, physiology and imaging are complementary to achieve good assessment of left main PCI. Dejan Milasinovic adds that different imaging tools can be used in different patients, so practitioners may choose between OCT and IVUS, depending on their main target of interest.
Find out the specifics...
